GILD’s Kite subsidiary reduces workforce 7%: https://www.fiercepharma.com/pharma/gilead-cuts-7-staff-kite-pharma-unit-refreshed-business-strategy-introduced Kite produces GILD’s two approved CAR-T products, Yescarta and Tecartus (#msg- 173310477). Is the timing of this announcement just a coincidence?